Evidence map›Paper›PMID 11517281›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2001

Nociceptin reduces epileptiform events in CA3 hippocampus via presynaptic and postsynaptic mechanisms.

M K Tallent, S G Madamba, G R Siggins

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 37 citations in OpenAlex.

  1. Synaptic Effects Induced by Alcohol.Current topics in behavioral neurosciences · 2025
    Review
  2. Role of nociceptin/orphanin FQ and nociceptin opioid peptide receptor in depression and antidepressant effects of nociceptin opioid peptide receptor antagonists.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2019
    Review
  3. Roles of KNeuropharmacology · 2019
    Article
  4. Article
  5. Nociceptin/orphanin FQ decreases glutamate transmission and blocks ethanol-induced effects in the central amygdala of naive and ethanol-dependent rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Article
  6. Synaptic effects induced by alcohol.Current topics in behavioral neurosciences · 2013
    Review
  7. Article
  8. Somatostatin: an endogenous antiepileptic.Molecular and cellular endocrinology · 2008
    Review
  9. Somatostatin receptor subtype 4 couples to the M-current to regulate seizures.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2008
    Article
  10. Article
  11. Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2002
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

M K TallentDepartment of Neuropharmacology, The Scripps Research Institute, La Jolla, California 92037, USA. mtallent@scripps.edu
S G Madamba
G R Siggins
Scripps Research Institute · US

Funding

MORPHINE-LIKE BRAIN PEPTIDES: CELLULAR NEUROBIOLOGYR01DA003665 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI SIGGINS, GEORGE ROBERT · 1985 to 2008
$2.2M
ROLE OF SOMATOSTATIN IN NORMAL AND EPILEPTIC BRAINR01NS038633 · NINDS · SCRIPPS RESEARCH INSTITUTE · PI TALLENT, MELANIE K · 1999 to 2002
$736k
NIDA NIH HHS DA03665NIDA NIH HHS R01 DA003665NINDS NIH HHS NS38633NINDS NIH HHS R01 NS038633
6 · The paper itself

Abstract

The opiate-like peptide nociceptin/orphanin FQ (Noc) and its receptor [opiate receptor-like receptor (ORL-1)] are highly expressed in the hippocampus. Noc has inhibitory postsynaptic actions in CA1, CA3, and the dentate and seems to lack the disinhibitory, excitatory actions demonstrated for some opiate peptides in the hippocampus. The CA3 hippocampal region is important in the generation of hippocampal seizures. Therefore, we tested the action of Noc on spontaneous epileptiform activity recorded extracellularly or intracellularly in CA3 and generated by removal of Mg(2+) from the bathing solution or by raising extracellular K(+) from 3.5 to 7.5 mm. Superfusion of Noc robustly depressed spontaneous bursting without desensitization. The ORL-1 antagonist [Phe(1)Psi(CH(2)-NH)Gly(2)]NC(1-13)NH(2) (1-2 microm) greatly attenuated the reduction of spontaneous bursting by Noc. To characterize the cellular mechanism of action of Noc, we recorded intracellularly from CA3 pyramidal neurons. Noc reduced EPSCs evoked by stimulating either mossy or associational/commissural fibers. Analysis of miniature EPSCs using whole-cell voltage-clamp recording suggests that Noc acts presynaptically to inhibit glutamate release. This is the first demonstration of a presynaptic effect for Noc in the hippocampus. Noc also increased K(+) currents in CA3 pyramidal neurons, including the voltage-sensitive M-current. Blocking the M-current with linopirdine increased the duration of individual CA3 bursts but did not attenuate Noc-mediated inhibition of bursting. Thus, Noc acts via multiple mechanisms to reduce excitation in CA3. However, Noc inhibition of epileptiform events is not dependent on augmentation of the M-current.

Indexed as

AnimalsEpilepsyExcitatory Postsynaptic PotentialsGlutamic AcidHippocampusIndolesIn Vitro TechniquesMagnesiumMaleMossy Fibers, HippocampalNociceptinOpioid PeptidesPatch-Clamp TechniquesPotassiumPyramidal CellsPyridinesGlutamic AcidIndoleslinopirdineMagnesiumNociceptinOpioid PeptidesPotassiumPyridines

Identifiers

PMID11517281
PMCPMC6763093
OpenAlexW2125095121

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.